2784.T Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 geg. 2024 @ 09:15):

Stats
Šios dienos apimtis	605 300
Vidutinė apimtis	460 974
Rinkos kapitalizacija	446.62B
EPS	¥0 ( 2024-02-07 )
Kita pelno data	( ¥38.32 ) 2024-05-13
Last Dividend	¥29.00 ( 2023-03-30 )
Next Dividend	¥0 ( N/A )
P/E	14.74
ATR14	¥0.991 (0.04%)

Tūris Koreliacija

Ilgas: 0.56 (weak)

Trumpas: 0.92 (very strong)

Signal:(79.117) Expect same movement, but be aware

Alfresa Holdings Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Alfresa Holdings Koreliacija - Valiuta/Žaliavos

0.46
( neutral )

0.52
( weak )

0.10
( neutral )

0.28
( neutral )

-0.81
( strong negative )

-0.84
( strong negative )

Alfresa Holdings Finansinės ataskaitos

Annual	2022
Pajamos:	¥2 696.07B
Bruto pelnas:	¥192.09B (7.12 %)
EPS:	¥127.42

FY	2022
Pajamos:	¥2 696.07B
Bruto pelnas:	¥192.09B (7.12 %)
EPS:	¥127.42

FY	2022
Pajamos:	¥2 585.64B
Bruto pelnas:	¥187.47B (7.25 %)
EPS:	¥153.57

FY	2021
Pajamos:	¥2 603.26B
Bruto pelnas:	¥175.54B (6.74 %)
EPS:	¥115.75

Financial Reports:

No articles found.

Alfresa Holdings Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
¥28.00 (N/A)	¥0 (N/A)	¥29.00 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)	¥0 (N/A)

Alfresa Holdings Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.59 - good (95.92%) | Divividend Growth Potential Score: 2.58 - Decrease likely (48.32%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	¥8.75	2006-03-28
Last Dividend	¥29.00	2023-03-30
Next Dividend	¥0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	36	--
Total Paid Out	¥544.25	--
Avg. Dividend % Per Year	0.00%	--
Score	3.19	--
Div. Sustainability Score	9.59
Div.Growth Potential Score	2.58
Div. Directional Score	6.09	--

Next Divdend (Est)
(2024-07-03)

¥0 Estimate 1.27 %

Dividend Stability

0.10 Bad

Dividend Score

3.19

Pay Frequency

Semi-Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for JPX

Symbol	Title	Last dividend	Frequency	Yearly Dividend
9531.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
8174.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
7552.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6762.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
6101.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
4812.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
4026.T	Ex Dividend Knight	2023-10-30	Semi-Annually	0.00%
3242.T	Ex Dividend Knight	2023-12-28	Semi-Annually	0.00%
2267.T	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
9042.T	Ex Dividend Junior	2023-09-28	Semi-Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0113	1.500	9.77	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0212	1.200	9.29	10.00	[0 - 0.3]
returnOnEquityTTM	0.0671	1.500	-0.365	-0.548	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.213	0.800	8.94	7.15	[1 - 3]
quickRatioTTM	0.923	0.800	9.28	7.42	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0.0200	-1.500	9.67	-10.00	[0 - 0.6]
interestCoverageTTM	488.93	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0646	-1.500	9.74	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.0724	1.000	-2.13	-2.13	[0.2 - 0.8]
operatingProfitMarginTTM	0.0142	1.000	-1.716	-1.716	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.897	1.000	6.13	6.13	[0.2 - 2]
assetTurnoverTTM	1.885	0.800	0.766	0.613	[0.5 - 2]
Total Score				9.59

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	13.97	1.000	8.69	0	[1 - 100]
returnOnEquityTTM	0.0671	2.50	-0.235	-0.548	[0.1 - 1.5]
freeCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.421	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	143.79	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.820	1.500	-8.80	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.00951	1.000	-2.26	0	[0.1 - 0.5]
Total Score				2.58

Alfresa Holdings

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.